Literature DB >> 23873661

Standardized uptake value in high uptake area on positron emission tomography with 18F-FRP170 as a hypoxic cell tracer correlates with intratumoral oxygen pressure in glioblastoma.

Takaaki Beppu1, Kazunori Terasaki, Toshiaki Sasaki, Shunrou Fujiwara, Hideki Matsuura, Kuniaki Ogasawara, Koichiro Sera, Noriyuki Yamada, Noriyuki Uesugi, Tamotsu Sugai, Kohsuke Kudo, Makoto Sasaki, Shigeru Ehara, Ren Iwata, Yoshihiro Takai.   

Abstract

PURPOSE: The aim of this study was to clarify the reliability of positron emission tomography (PET) using a new hypoxic cell tracer, 1-(2-[(18)F]fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole ((18)F-FRP170). PROCEDURES: Twelve patients with glioblastoma underwent (18)F-FRP170 PET before tumor resection. Mean standardized uptake value (SUV) and normalized SUV were calculated at regions within a tumor showing high (high-uptake area) and relatively low (low-uptake area) accumulations of (18)F-FRP170. In these areas, intratumoral oxygen pressure (tpO2) was measured using microelectrodes during tumor resection.
RESULTS: Mean tpO2 was significantly lower in the high-uptake area than in the low-uptake area. A significant negative correlation was evident between normalized SUV and tpO2 in the high-uptake area.
CONCLUSION: The present findings suggest that high accumulation on (18)F-FRP170 PET represents viable hypoxic tissues in glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23873661     DOI: 10.1007/s11307-013-0670-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  31 in total

1.  Imaging of ischemic but viable myocardium using a new 18F-labeled 2-nitroimidazole analog, 18F-FRP170.

Authors:  Tomohiro Kaneta; Yoshihiro Takai; Yutaka Kagaya; Yuriko Yamane; Hiroaki Wada; Masahiro Yuki; Ren Iwata; Michihiko Tsujitani; Shoki Takahashi; Shogo Yamada
Journal:  J Nucl Med       Date:  2002-01       Impact factor: 10.057

Review 2.  Imaging hypoxia in gliomas.

Authors:  I Mendichovszky; A Jackson
Journal:  Br J Radiol       Date:  2011-12       Impact factor: 3.039

3.  Evidence for acutely hypoxic cells in mouse tumours, and a possible mechanism of reoxygenation.

Authors:  J M Brown
Journal:  Br J Radiol       Date:  1979-08       Impact factor: 3.039

4.  Trans sodium crocetinate: functional neuroimaging studies in a hypoxic brain tumor.

Authors:  Jason P Sheehan; Britney Popp; Stephen Monteith; Sushila Toulmin; Jennifer Tomlinson; Jessica Martin; Christopher P Cifarelli; Dae-Hee Lee; Deric M Park
Journal:  J Neurosurg       Date:  2011-06-17       Impact factor: 5.115

Review 5.  Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures.

Authors:  Randy L Jensen
Journal:  Neurosurg Focus       Date:  2006-04-15       Impact factor: 4.047

6.  Hypoxia imaging with the nitroimidazole 18F-FAZA PET tracer: a comparison with OxyLite, EPR oximetry and 19F-MRI relaxometry.

Authors:  Ly-Binh-An Tran; Anne Bol; Daniel Labar; Bénédicte Jordan; Julie Magat; Lionel Mignion; Vincent Grégoire; Bernard Gallez
Journal:  Radiother Oncol       Date:  2012-06-06       Impact factor: 6.280

7.  Prognostic impact of hypoxia imaging with 18F-misonidazole PET in non-small cell lung cancer and head and neck cancer before radiotherapy.

Authors:  Susanne-Martina Eschmann; Frank Paulsen; Matthias Reimold; Helmut Dittmann; Stefan Welz; Gerald Reischl; Hans-Juergen Machulla; Roland Bares
Journal:  J Nucl Med       Date:  2005-02       Impact factor: 10.057

8.  In vivo colocalization of 2-nitroimidazole EF5 fluorescence intensity and electron paramagnetic resonance oximetry in mouse tumors.

Authors:  Pierre Mahy; Marc De Bast; Bernard Gallez; John Gueulette; Cameron J Koch; Pierre Scalliet; Vincent Grégoire
Journal:  Radiother Oncol       Date:  2003-04       Impact factor: 6.280

9.  Imaging of hypoxic lesions in patients with gliomas by using positron emission tomography with 1-(2-[18F] fluoro-1-[hydroxymethyl]ethoxy)methyl-2-nitroimidazole, a new 18F-labeled 2-nitroimidazole analog.

Authors:  Ichiyo Shibahara; Toshihiro Kumabe; Masayuki Kanamori; Ryuta Saito; Yukihiko Sonoda; Mika Watanabe; Ren Iwata; Shuichi Higano; Kentaro Takanami; Yoshihiro Takai; Teiji Tominaga
Journal:  J Neurosurg       Date:  2010-08       Impact factor: 5.115

10.  Initial results of hypoxia imaging using 1-alpha-D: -(5-deoxy-5-[18F]-fluoroarabinofuranosyl)-2-nitroimidazole ( 18F-FAZA).

Authors:  Ernst J Postema; Alexander J B McEwan; Terence A Riauka; Piyush Kumar; Dacia A Richmond; Douglas N Abrams; Leonard I Wiebe
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-05-09       Impact factor: 9.236

View more
  10 in total

1.  Reduced Hypoxic Tissue and Cognitive Improvement after Revascularization Surgery for Chronic Cerebral Ischemia.

Authors:  Yasuyoshi Shimada; Masakazu Kobayashi; Kenji Yoshida; Kazunori Terasaki; Shunrou Fujiwara; Yoshitaka Kubo; Takaaki Beppu; Kuniaki Ogasawara
Journal:  Cerebrovasc Dis       Date:  2019-02-15       Impact factor: 2.762

2.  High-uptake areas on positron emission tomography with the hypoxic radiotracer (18)F-FRP170 in glioblastomas include regions retaining proliferative activity under hypoxia.

Authors:  Takaaki Beppu; Toshiaki Sasaki; Kazunori Terasaki; Hiroaki Saura; Hideki Mtsuura; Kuniaki Ogasawara; Makoto Sasaki; Shigeru Ehara; Ren Iwata; Yoshihiro Takai
Journal:  Ann Nucl Med       Date:  2015-01-25       Impact factor: 2.668

Review 3.  Imaging tumour hypoxia with positron emission tomography.

Authors:  I N Fleming; R Manavaki; P J Blower; C West; K J Williams; A L Harris; J Domarkas; S Lord; C Baldry; F J Gilbert
Journal:  Br J Cancer       Date:  2014-12-16       Impact factor: 7.640

Review 4.  Molecular mechanisms of hypoxia in cancer.

Authors:  Amarnath Challapalli; Laurence Carroll; Eric O Aboagye
Journal:  Clin Transl Imaging       Date:  2017-05-11

Review 5.  Oxygen Sensing, Hypoxia Tracing and in Vivo Imaging with Functional Metalloprobes for the Early Detection of Non-communicable Diseases.

Authors:  Vincenzo Mirabello; Fernando Cortezon-Tamarit; Sofia I Pascu
Journal:  Front Chem       Date:  2018-02-23       Impact factor: 5.221

Review 6.  The Added Value of Diagnostic and Theranostic PET Imaging for the Treatment of CNS Tumors.

Authors:  Ilanah J Pruis; Guus A M S van Dongen; Sophie E M Veldhuijzen van Zanten
Journal:  Int J Mol Sci       Date:  2020-02-04       Impact factor: 5.923

Review 7.  Hypoxia and the phenomenon of immune exclusion.

Authors:  Violena Pietrobon; Francesco M Marincola
Journal:  J Transl Med       Date:  2021-01-06       Impact factor: 5.531

8.  Non-conventional and Investigational PET Radiotracers for Breast Cancer: A Systematic Review.

Authors:  Michele Balma; Virginia Liberini; Manuela Racca; Riccardo Laudicella; Matteo Bauckneht; Ambra Buschiazzo; Daniele Giovanni Nicolotti; Simona Peano; Andrea Bianchi; Giovanni Albano; Natale Quartuccio; Ronan Abgral; Silvia Daniela Morbelli; Calogero D'Alessandria; Enzo Terreno; Martin William Huellner; Alberto Papaleo; Désirée Deandreis
Journal:  Front Med (Lausanne)       Date:  2022-04-12

Review 9.  Imaging Modalities to Assess Oxygen Status in Glioblastoma.

Authors:  Aurélien Corroyer-Dulmont; Ararat Chakhoyan; Solène Collet; Lucile Durand; Eric T MacKenzie; Edwige Petit; Myriam Bernaudin; Omar Touzani; Samuel Valable
Journal:  Front Med (Lausanne)       Date:  2015-08-19

Review 10.  A perspective on the radiopharmaceutical requirements for imaging and therapy of glioblastoma.

Authors:  Julie Bolcaen; Janke Kleynhans; Shankari Nair; Jeroen Verhoeven; Ingeborg Goethals; Mike Sathekge; Charlot Vandevoorde; Thomas Ebenhan
Journal:  Theranostics       Date:  2021-07-06       Impact factor: 11.556

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.